MarginsXMarginsX
Home › Markets › NPHC

Nutra Pharma Corp (NPHC)

NPHC is quoted over the counter, not listed on an exchange. Nutra Pharma Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.0002
0.0% on the day
1-year return
+100.0%
Market cap
$1.4M
Nano cap. From the Nov 13, 2026 close × 7.16B shares (10-Q cover page, Aug 19, 2026)
P/E and P/S
Net loss over the period · 8.9×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerNPHC, quoted over the counter
SEC CIK0001119643
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressBoca Raton, FL
Incorporated inCA

Warning signs

Cash runway
0.2 months
$22K cash at March 31, 2026
Share count, 1 year
+0.8%
2025-09-03 to 2026-08-19
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"There is substantial doubt regarding our ability to continue as a going concern which is contingent upon our ability to secure additional financing, increase ownership equity and attain profitable operations."
10-Q 2026-08-19
Cash and burn$22K cash; operating cash flow -$262K a quarter.Report 2026-06-30
Shares outstanding7,159,727,214 (2026-08-19); 7,099,727,214 a year earlier.Cover page 2026-08-19
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorAstra Audit & Advisory, LLC, Tampa, Florida, United States; changed auditors 1 time in 24 months8-K 4.01 2025-09-03
Late filings, 12 months1 NT noticeNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$34K-$3.9M-$251KNot filed$12.6M$161K10-Q 2026-08-19
Q1 2026
2026-03-31
$27K-$460K-$328K$22K$10.0M$211K10-Q 2026-05-29
Q4 2025
2025-12-31
$29K-$489K-$220K$12K$9.8M$258K10-K 2026-05-20
Q3 2025
2025-09-30
$70K-$524K-$251K$4K$9.7M$311K10-Q 2026-04-06
Q2 2025
2025-06-30
$85K$370K-$288K$79K$9.5M$315K10-Q 2026-08-19
Q1 2025
2025-03-31
$74K-$1.4M-$405K$14K$9.1M$283K10-Q 2026-05-29
Q4 2024
2024-12-31
$82K-$231K-$178K$36K$8.6M$246K10-K 2026-05-20
Q3 2024
2024-09-30
$75K-$261K$19K$0$8.4M$211K10-Q 2026-04-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2011-01-06
Latest annual report10-K2026-05-20
Latest quarterly / interim10-Q2026-08-19
Latest current report8-K2026-09-02
Latest proxyDEF 14A2015-03-17

Source: SEC EDGAR submissions feed, 350 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier